Search
for
Sort by
Research 181–210 of 599
- N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Development of a new GC–MS/MS method for the determination of metformin in human hair
- Synthetic studies toward the development of novel minoxidil analogs and conjugates with polyamines
- Transcriptomic inspection revealed a possible pathway regulating the formation of the high-quality brush hair in Chinese Haimen goat ( <i>Capra hircus</i> )
- Drug eruptions in dermatology
- Clinical Development of Topoisomerase-Interactive Drugs
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
- Hormones
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Steroid Hormones
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Monocyclic Aromatic Compounds
- Alopecia Associated with Sulfasalazine
- MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Hair follicle-derived epithelial sheet has potential in vitiligo treatment
- DNA Methylation‐Regulated ZDHHC17 Promotes the Risk of Facial Skin Aging
- Metabolomic and lipidomic atlas of human hair across its length
- <i>Malassezia</i> and the Asian menopausal skin
- Vitex negundo: A comprehensive review of phytoconstituents, their derivatives, and therapeutic applications
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Drug pipeline 2Q22 — a downturn in approvals
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- Hormone Blocking Anticancer Drugs
- Syndromes of Severe Insulin Resistance (SSIRs)
- Genetically Altered Expression of Spermidine/Spermine N1-Acetyltransferase Affects Fat Metabolism in Mice via Acetyl-CoA